![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 18, 18130-18137, May 6, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Pak1 (p21-activated kinase 1), a conserved, mammalian signaling kinase, is a downstream effector of small GTPases Rac1 and Cdc42 and of growth factor signaling. Until now, a major focus of study has been on the cytosolic functions of Pak1, where it is an important modulator of cytoskeletal reorganization, consequently playing a major role in cell survival, migration, and invasion. In this report, we demonstrate the nuclear localization of Pak1 upon stimulation by epidermal growth factor. Three nuclear localization signals (NLSs) were identified in the N-terminal domain of Pak1. With mutational analysis, the importance of each NLS was elucidated. Mutation of all three NLSs eliminated the nuclear localization of Pak1. Expression of Pak1 as a fusion protein with Gal4-DNA binding domain and Gal4-luciferase activity showed that Pak1 might increase transcription. To identify the potential targets of nuclear Pak1, we used a Pak1-specific chromatin immunoprecipitation-based screening assay and identified a series of Pak1-interacting target chromatins, including phosphofructokinase-muscle isoform (PFK-M) and nuclear factor of activated T-cell (NFAT1) genes. Pak1 associated with the upstream enhancer sequence and promoter of PFK-M and was involved in the stimulation of the PFK-M expression. It also associated with a portion of the NFAT1 gene and its upstream region, leading to the repression of NFAT1 expression. These investigations provide proof-of-principle evidence that Pak1 could influence the expression of its putative chromatin targets in both a positive and a negative manner. Together, for the first time, these findings defined the NLSs of the Pak1, its association with chromatin, and the resulting modulation of transcription, thus opening new avenues to further the search for nuclear Pak1 functions and identify putative Pak1-interacting nuclear proteins.
Received for publication, November 8, 2004 , and in revised form, February 15, 2005.
* This study was supported by National Institutes of Health grants CA90970, CA109379, and CA 98823 (R. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 713-745-3558; Fax: 713-745-3792; E-mail: rkumar{at}mdanderson.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Karjalainen, E. Kakkonen, P. Upla, H. Paloranta, P. Kankaanpaa, P. Liberali, G. H. Renkema, T. Hyypia, J. Heino, and V. Marjomaki A Raft-derived, Pak1-regulated Entry Participates in {alpha}2{beta}1 Integrin-dependent Sorting to Caveosomes Mol. Biol. Cell, July 1, 2008; 19(7): 2857 - 2869. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Michaelson, W. Abidi, D. Guardavaccaro, M. Zhou, I. Ahearn, M. Pagano, and M. R. Philips Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division J. Cell Biol., May 1, 2008; 181(3): 485 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Acconcia, C. J. Barnes, R. R. Singh, A. H. Talukder, and R. Kumar Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase PNAS, April 17, 2007; 104(16): 6782 - 6787. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Esufali, G. S. Charames, V. V. Pethe, P. Buongiorno, and B. Bapat Activation of Tumor-Specific Splice Variant Rac1b by Dishevelled Promotes Canonical Wnt Signaling and Decreased Adhesion of Colorectal Cancer Cells Cancer Res., March 15, 2007; 67(6): 2469 - 2479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Rayala, P. R. Molli, and R. Kumar Nuclear p21-Activated Kinase 1 in Breast Cancer Packs Off Tamoxifen Sensitivity. Cancer Res., June 15, 2006; 66(12): 5985 - 5988. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Holm, S. Rayala, K. Jirstrom, O. Stal, R. Kumar, and G. Landberg Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J Natl Cancer Inst, May 17, 2006; 98(10): 671 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cotteret and J. Chernoff Nucleocytoplasmic Shuttling of Pak5 Regulates Its Antiapoptotic Properties Mol. Cell. Biol., April 15, 2006; 26(8): 3215 - 3230. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |